A prospective, multicenter, randomized, parallel controlled, subject and evaluator blind, non-inferior clinical trial evaluating the efficacy and safety of injectable tissue matrix fillers for the correction of nasolabial wrinkles

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Test Group:Tissue matri Xfiller for injection;Control Group:Collagen implants; CONDITION: Nasolabial wrinkles PRIMARY OUTCOME: Efficiency rate; SECONDARY OUTCOME: The efficiency of wrinkle correction;The improvement rate of the overall beauty effect;Subject satisfaction; INCLUSION CRITERIA: 1. Aged >= 18 years old, gender unlimited; 2. Subjects who are willing to correct nasolabial wrinkles; 3. According to the blind evaluator, the nasolabial wrinkle Severity Rating Scale (WSRS) was moderate or severe degree (level 3 on both sides or level 4 on both sides); 4. Be able to tolerate mild pain; 5. Subject has reasonable expectations, understands and complies with study procedures and all visit schedules; 6. Subjects who voluntarily decided to participate in the study and signed informed consent.
Epistemonikos ID: 14bde879a32559e67f45bfe9c23da97df6a17034
First added on: Feb 20, 2024